What is Precision Oncology Ireland?
Precision Oncology Ireland (POI) is a consortium of 5 Irish Universities, 6 Irish Charities, and 9 industry partners aiming to develop new diagnostics and therapeutics for personalised cancer treatment. Officially launched in November 2019, the consortium is part-funded by Science Foundation Ireland under their Strategic Partnership Programme, and is co-ordinated by Systems Biology Ireland.
POI is led by Prof. Walter Kolch, Director of Systems Biology Ireland in UCD, and a leading international proponent of precision medicine. The Deputy Director is Prof. William Gallagher, Professor of Cancer Biology and Director of the Conway Institute in UCD.
The combined SFI, charity, and industrial funding commitment will total €11.9 million over the next five years. This is the first time that researchers, charities and industry have combined forces in this way, with a joint view of achieving greater impact for patients by uniting investments in the POI programme.